Paul Kormelink PhD

Paul Groot Kormelink obtained his PhD from the University of Leuven in Belgium and continued his focus on ion channels during a six-year Postdoc at University College London in the UK. In 2005, he joined the ion channel unit at Novartis (part of the respiratory disease area located in Horsham, UK) before switching to the musculoskeletal disease area in Basel, Switzerland in 2013. He is an experienced drug discovery scientist with over 20 years at Novartis, leading several membrane protein drug targets (ion channels and GPCRs) within the respiratory and neuromuscular disease area – most recently on GPR126.